1,3-Dimesityl-1H-imidazol-3-ium hydrogen carbonate, 98.0%, 1g

Methyl imidazo[1,2-a]pyridine-7-carboxylate, 95.0%, 25g

(4-(N-(2-((tert-Butoxycarbonyl)amino)ethyl)sulfamoyl)phenyl)boronic acid, 96%, 250mg

tert-Butyl (2R,4S)-4-amino-2-methylpiperidine-1-carboxylate hydrochloride, 98%, 100mg

Closure caps SILICOSEN®, C-20, Gesch. front, 12-20 mm 10 pcs

(2S,4R)-1-((Benzyloxy)carbonyl)-4-((tert-butoxycarbonyl)amino)pyrrolidine-2-carboxylic acid, 98%, 250mg

1-NAPHTHYLIODIDE, 98.00%, 25g

((3aR,4R,6R,6aR)-6-(4-Chloro-7H-pyrrolo[2,3-d]pyrimidin-7-yl)-2,2,3a-trimethyltetrahydrofuro[3,4-d][1,3]dioxol-4-yl)methanol, 98%, 5g

N-Boc-2-Cyclohexyl-D-glycine, 97.0%, 25g

1-(oxetan-3-yl)ethan-1-one, 97.0%, 500mg

5-(3-Fluoro-phenyl)-[1,3,4]oxadiazole-2-thiol, 95.0%, 5g

TERT-BUTYL (2-(4-METHYLPIPERAZIN-1-YL)ETHYL)CARBAMATE, 95.0%, 5g

Filtration unit with SFCA membrane Pore size 0.45 μm, 500 ml, 500 ml, 90 mm, 12 Piece(s)